G1 Therapeutics Announces Upcoming Presentation at the 2024
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting...
Stay updated with breaking news from Efficacy Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting...
RESEARCH TRIANGLE PARK, N.C., May 23, 2024 -- G1 Therapeutics, Inc. , a commercial-stage oncology company, today announced that mature Phase 2 results describing the positive impact of trilaciclib...
MALVERN, Pa., May 20, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Arun...
Updated results reinforce the potential of TAR-210 to transform treatment of non-muscle-invasive bladder cancer with fibroblast growth factor receptor...
MALVERN, Pa., May 02, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Arun...